Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument.


Journal

BMC family practice
ISSN: 1471-2296
Titre abrégé: BMC Fam Pract
Pays: England
ID NLM: 100967792

Informations de publication

Date de publication:
07 06 2019
Historique:
received: 26 04 2019
accepted: 30 05 2019
entrez: 9 6 2019
pubmed: 9 6 2019
medline: 26 2 2020
Statut: epublish

Résumé

Patients with anemia are frequently encountered in primary care. Once anemia is detected, it is essential to define the type and identify the underlying cause prior to initiation of treatment. In most cases, the cause can be determined using information from the patient history, physical exam, and complete blood counts (CBC). Point of care testing of blood cell counts would speed up the work up of anemia patients. The aim of the present study was to evaluate if the HemoScreen™ instrument (PixCell Medical, Yokneam Ilit, Israel) could be used for primary care samples. It is a POCT instrument that utilizes single sample cuvettes and image analysis of full blood count including RBC, Hemoglobin, MCV, MCH, platelets, WBC, and WBC 5-part differential. We compared the HemoScreen™ and the Sysmex XN instrument results of 100 primary care patient samples focusing on the total white blood cells, red blood cell parameters RBC, Hemoglobin, MCH, MCV and platelets. Deming correlations between the HemoScreen™ and the Sysmex XN instruments for the CBC were WBC The HemoScreen™ instrument could provide rapid and accurate test results for evaluation of the red blood cell parameters in primary care. This new technology is interesting as it allows the analysis red blood cell parameters also at small primary care centers.

Sections du résumé

BACKGROUND
Patients with anemia are frequently encountered in primary care. Once anemia is detected, it is essential to define the type and identify the underlying cause prior to initiation of treatment. In most cases, the cause can be determined using information from the patient history, physical exam, and complete blood counts (CBC). Point of care testing of blood cell counts would speed up the work up of anemia patients. The aim of the present study was to evaluate if the HemoScreen™ instrument (PixCell Medical, Yokneam Ilit, Israel) could be used for primary care samples. It is a POCT instrument that utilizes single sample cuvettes and image analysis of full blood count including RBC, Hemoglobin, MCV, MCH, platelets, WBC, and WBC 5-part differential.
METHODS
We compared the HemoScreen™ and the Sysmex XN instrument results of 100 primary care patient samples focusing on the total white blood cells, red blood cell parameters RBC, Hemoglobin, MCH, MCV and platelets.
RESULTS
Deming correlations between the HemoScreen™ and the Sysmex XN instruments for the CBC were WBC
CONCLUSION
The HemoScreen™ instrument could provide rapid and accurate test results for evaluation of the red blood cell parameters in primary care. This new technology is interesting as it allows the analysis red blood cell parameters also at small primary care centers.

Identifiants

pubmed: 31174471
doi: 10.1186/s12875-019-0971-2
pii: 10.1186/s12875-019-0971-2
pmc: PMC6554883
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Références

Lancet. 1995 Oct 21;346(8982):1085-7
pubmed: 7564793
Avicenna J Med Biotechnol. 2017 Oct-Dec;9(4):196-200
pubmed: 29090069
Scand J Clin Lab Invest. 2004;64(4):385-98
pubmed: 15223702
Iran Red Crescent Med J. 2012 Jul;14(7):397-401
pubmed: 22997554
Lancet. 2007 Aug 11;370(9586):511-20
pubmed: 17693180
J Clin Pathol. 2016 Aug;69(8):720-5
pubmed: 26786235
Arch Intern Med. 2008 Nov 10;168(20):2238-44
pubmed: 19001201
Curr Med Res Opin. 2006 Feb;22(2):385-95
pubmed: 16466611
Ups J Med Sci. 2015 Mar;120(1):1-10
pubmed: 25622619
Postgrad Med. 2004 Nov;116(5 Suppl Anemia):7-11
pubmed: 19667678
Obstet Gynecol Clin North Am. 2016 Jun;43(2):247-64
pubmed: 27212091
Wien Med Wochenschr. 2012 Nov;162(21-22):478-88
pubmed: 23135251
Emerg Med Pract. 2013 Nov;15(11):1-15; quiz 15-6
pubmed: 24716235
JAMA. 1997 Mar 26;277(12):973-6
pubmed: 9091669

Auteurs

Anders Larsson (A)

Department of Medical Sciences, Section Clinical Chemistry, Uppsala University, Akademiska sjukhuset, entrance 61, 3rd floor, SE-751 85, Uppsala, Sweden. Anders.larsson@akademiska.se.

Lena Carlsson (L)

Department of Medical Sciences, Section Clinical Chemistry, Uppsala University, Akademiska sjukhuset, entrance 61, 3rd floor, SE-751 85, Uppsala, Sweden.

Bo Karlsson (B)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

Miklos Lipcsey (M)

The Hedenstierna Laboratory, CIRRUS, Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH